Suppression of proliferation, tumorigenicity and metastasis of lung cancer cells after their transduction by interferon-beta gene in baculovirus vector

Cytokine

Volumn 71, Issue 2, 2015, Pages 318-326

  Lykhova, Alexandra A ^a   Kudryavets, Yuri I ^a   Strokovska, Ludmila I ^b   Bezdenezhnykh, Natalia A ^a   Semesiuk, Nadiia I ^a   Adamenko, Inna N ^a   Anopriyenko, Olga V ^b   Vorontsova, Ada L ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

Interferon beta; Lewis lung carcinoma cells; Metastasis; Recombinant baculovirus; Tumorigenicity

Indexed keywords

BACULOVIRUS VECTOR; BETA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC TRANSDUCTION; IFN BETA GENE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LEWIS LUNG CARCINOMA CELL; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BACULOVIRIDAE; C57BL MOUSE; CANCER TRANSPLANTATION; GENE THERAPY; GENE VECTOR; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHENOTYPE; PROCEDURES; TUMOR CELL LINE;

MUS;

ANIMALS; BACULOVIRIDAE; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; GENETIC THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; INTERFERON-BETA; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHENOTYPE;

EID: 84916910828     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.10.029     Document Type: Article

References (35)

1. Li D., Ambrogio L., Shimamura T., Kubo S., Takahashi M., Chirieac L.R., et al. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene 2008, 27:4702-4711.
2. Huang W., Tian X.L., Wu Y.L., Zhong J., Yu L.F., Hu S.P., et al. Suppression of gastric cancer growth by baculovirus vector-mediated transfer of normal epithelial cell specific-1 gene. World J Gastroenterol 2008, 14:5810-5815.
3. Khalighinejad N., Hariri H., Behnamfar O., Yousefi A., Momeni A. Adenoviral gene therapy in gastric cancer: a review. World J Gastroenterol 2008, 14:180-184.
4. Lykhova A.A., Kudryavets Yu.I., Bezdenezhnykh N.A., Semesiuk N.I., Adamenko I.N., Vorontsova A.L. Suppression of tumorigenicity and metastatic potential of melanoma cells by transduction of interferon-beta gene. Biopolym Cell 2014, 30(1):61-67.
5. Boyce F.M., Bucher N.L. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996, 93:2348-2352.
6. Matilainen H., Rinne J., Gilbert L., Marjomaki V., Reunanen H., Oker-Blom C. Baculovirus entry into human hepatoma cells. J Virol 2005, 79:15452-15459.
7. Jarvis D.L., Garcia A. Long-term stability of baculoviruses stored under various conditions. Biotechniques 1994, 16:508-513.
8. Heideman D.A. Gene therapy and virotherapy of gastric cancer: preclinical results and clinical developments. Dig Dis 2004, 22:374-379.
9. Hussein A.M. The potential application of gene transfer in the treatment of patients with cancer: a concise review. Cancer Invest 1996, 14:343-352.
10. Rozera C., Carlei D., Lollini P.L., De Giovanni C., Musiani P., Di Carlo E., et al. Interferon (IFN)-β gene transfer into TS/A adenocarcinoma cells and comparison with IFN-α Am. J Pathol 1999, 4:1211-1222.
11. Kalvakolanu D.V. Interferons and cell growth control. Histol Histopathol 2000, 15:523-537.
12. Johns T.G., Mackay I.R., Callister K.A., Hertzog P.J., Devenish R.J. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. J Natl Cancer Inst 1992, 84:1185-1190.
13. Chawla-Sarkar M., Leaman D.W., Borden E.C. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res 2001, 7:1821-1831.
14. Qin X.Q., Beckham C., Brown J.L., Lukashev M., Barsoum J. Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models. Mol Ther 2001, 4:356-364.
15. Brierley M.M., Fish E.N. IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res 2002, 22:835-845.
16. Simmons D.P., Wearsch P.A., Canaday D.H., Meyerson H.J., Liu Yi.C., Wang Y., et al. Type I interferon drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing. J Immunol 2012, 188:3116-3126.
17. Deonarain R., Verma A., Porter A.C.G., Gewert D.R., Platanias L.C., Fish E.N. Critical roles for IFN-β in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor α. Proc Natl Acad Sci USA 2003, 100:13453-13458.
18. Salmon P., LeCotonnec J.Y., Galazka A., Abdul-Ahad A., Darragh A. Pharmacokinetics and pharmacodynamics of recombinant human interferon-beta in healthy male volunteers. J Interferon Cytokine Res 1996, 10:759-764.
19. Fierlbeck G., Ulmer A., Schreiner T., Stroebel W., Schiebel U., Brzoska J. Pharmacodynamics of recombinant IFN-β during long-term treatment of malignant melanoma. J Interferon Cytokine Res 1996, 10:777-781.
20. Vagyna I.N., Anopriyenko O.V., Zaharuk E.A., Gorchev V.F., Strokovska L.I., Solomko A.P. Efficient gene delivery into mammalian cells by baculovirus vector in vitro. Biopolym Cell 2008, 24(6):508-512.
21. Anopriyenko O.V., Vagyna I.N., Zakharuk O.A., Strokovska L.I., Solomko O.P. Baculovirus vectors As-CMV-GFP, As-M-GFP and As-IFN-GFP for eficient gene transfer to the mammalian cells. Bull Ukr Assoc Geneticist Breeder 2010, 8(1):3-9.
22. Kudryavets Yu.I., Didkovskaya L.P. A recombinant tumour necrosis factor promotes the formation of hematogenic metastases in lungs of C57BL/6 mice. Exp Oncol 1990, 12(2):47-50.
23. Animal Cell Culture A practical approach 1989, Mir, Moscow. R.I. Freshney (Ed.).
24. Vorontsova A.L., Kudryavets Yu.I., Fadeev V.A., Balitsky K.P. Antimetastatic action of interferon in the surgical removal of experimental tumours. Exp Oncol 1983, 5(5):45-49.
25. Vega-Avila E., Pugsley M.K. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc 2011, 54:10-14.
26. Gluzman D.F., Abramenko I.V., Sklyarenko L.M., Kryachok I.A., Nadgornaya V.A. Diagnosis of leukemia, atlas and practical guide 2000, Morion, Kiev.
27. Detre S., Saccani Jotti G., Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. Clin Pathol 1995, 48:876-878.
28. de Moraes M., de Lucena H.F., de Azevedo P.R., Queiroz L.M., Costa L. Ade, Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. Arch Oral Biol 2011, 56:1256-1263.
29. Zhang X., Xu L., Qiang Yu. Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth. Mol Cancer 2010, 9(7):1-11.
30. Hamburger A.W., Lurie K.A., Condon M.E. Stimulation of anchorage-independent growth of human tumor cells by interleukin 1. Cancer Res 1987, 47:5612-5615.
31. Lackner A., Kreidl E., Peter-Vörösmarty B., Spiegl-Kreinecker S., Berger W., Grusch M. Stable protein expression in mammalian cells using baculoviruses. Methods Mol Biol 2012, 801:75-92.
32. Chen G.Y., Shiah H.C., Su H.J., Chen C.Y., Chuang Y.J., Lo W.H., et al. Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 pathway. J Virol 2009, 83(20):10548-10556.
33. Chuang C.K., Wong T.H., Hwang S.M., Chang Y.H., Chen G.Y., Chiu Y.C., et al. Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther 2009, 17(5):889-896.
34. Kameron I.L., Pool T.B. The transformed cell 1981, Academic Press.
35. Qin X.Q., Tao N., Dergay A., Moy P., Fawell S., Davis A., et al. Interferon-β gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice. PNAS 1998, 95(24):14411-14416.